Literature DB >> 30770232

Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism.

Mohammad Reza Movahed1, Rostam Khoubyari2, Mehrnoosh Hashemzadeh3, Mehrtash Hashemzadeh4.   

Abstract

BACKGROUND: Obesity is associated with many cardiovascular risk factors. This study aimed to evaluate the independent association between obesity and pulmonary embolism.
METHODS: We used the International Classification of Diseases, Ninth Revision, Codes for obesity and pulmonary embolism from the Nationwide Inpatient Sample database. We randomly selected the 1992 and 2002 databases, which are 10 years apart, as the two independent population samples. We performed uni- and multivariate analyses to evaluate any association between obesity and pulmonary embolism.
RESULTS: The 1992 database consisted of a total of 6,195,744 patients. Obesity was present in 93,568 patients. Pulmonary embolism occurred in 0.7% of obese patients vs. 0.3% of the control population (odds ratio [OR], 2.32; 95% confidence interval [CI] 2.2-2.4; p<0.0001). The 2002 database consisted of a total of 299,010 obese patients. Pulmonary embolism occurred in 0.9% of obese patients vs. 0.4% of the control population (OR, 2.36; 95% CI, 2.19-2.41; p<0.0001). After adjusting for age and many risk factors, obesity remained strongly associated with pulmonary embolism (for 1992, OR, 2.1; 95% CI, 2.0-2.3; p<0.0001 and for 2002, OR, 2.2; 95% CI, 2.1-2.3; p<0.0001).
CONCLUSION: Obesity has been consistently associated with pulmonary embolism over the years studied using a large inpatient database. This association has been persistent over a period of 10 years and is consistent with the negative effects of obesity on the cardiopulmonary system.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Deep vein thrombosis; Obesity; Pulmonary embolism; Thromboembolic events; Thromboembolism

Year:  2019        PMID: 30770232     DOI: 10.1016/j.resinv.2019.01.003

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  8 in total

Review 1.  The potential impacts of obesity on COVID-19.

Authors:  Ahmed Abdalazim Dafallah Albashir
Journal:  Clin Med (Lond)       Date:  2020-06-22       Impact factor: 2.659

2.  Excess Body Fatness during Early to Mid-Adulthood and Survival from Colorectal and Breast Cancer: A Pooled Analysis of Five International Cohort Studies.

Authors:  Hadrien Charvat; Heinz Freisling; Hwayoung Noh; Mia M Gaudet; Marc J Gunter; Amanda J Cross; Konstantinos K Tsilidis; Anne Tjønneland; Verena Katzke; Manuela Bergmann; Claudia Agnoli; Charlotta Rylander; Guri Skeie; Paula Jakszyn; Ann H Rosendahl; Malin Sund; Gianluca Severi; Shoichiro Tsugane; Norie Sawada; Hermann Brenner; Hans-Olov Adami; Elisabete Weiderpass; Isabelle Soerjomataram; Melina Arnold
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-11-15       Impact factor: 4.090

3.  Association between obesity and venous thromboembolism.

Authors:  Cristina Hotoleanu
Journal:  Med Pharm Rep       Date:  2020-04-22

4.  Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor.

Authors:  Nuria Rodríguez-Núñez; Alberto Ruano-Raviña; Adriana Lama; Lucía Ferreiro; Jorge Ricoy; José M Álvarez-Dobaño; Juan Suárez-Antelo; M Elena Toubes; Carlos Rábade; Antonio Golpe; Tamara Lourido; Francisco Javier González-Barcala; Luis Valdés
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 3.005

5.  The Role of Biochemical and Respiratory Markers in the Mortality of Patients With SARS-CoV-2 Infection in a Mexican Population.

Authors:  Jeshua Altuve-Quiroz; Carla Fernández-Reynoso; Michel G Mondragón-Soto; José I Juárez-Ramírez
Journal:  Cureus       Date:  2022-06-23

6.  Pulmonary Embolism during a Retrial of Low-dose Clozapine.

Authors:  Gregg Alan Robbins-Welty; Shannon Coats; Andrew N Tuck; Bryan K Lao; Zachary Lane
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

Review 7.  Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Authors:  Yue Zhou; Jingwei Chi; Wenshan Lv; Yangang Wang
Journal:  Diabetes Metab Res Rev       Date:  2020-07-20       Impact factor: 8.128

8.  Risk of COVID-19 for patients with obesity.

Authors:  Radwan Kassir
Journal:  Obes Rev       Date:  2020-04-13       Impact factor: 9.213

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.